Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
Por:
Isla D, Arriola E, Campelo M, Marti C, Tain P, Vega A, Piqueras M, Leon L, Calderon V, Rodriguez J, Majem M, Sanchez-Hernandez A, de la Rosa C, Cabellos R, Marti-Ciriquian J, Paul A, Cordero M, Mellen A, Baez L, Zugazagoitia J
Publicada:
1 abr 2022
Ahead of Print:
1 abr 2022
Resumen:
|